Very nigh cytochrome P4501A2 activity and nonresponse to clozapine

被引:45
作者
Bender, S [1 ]
机构
[1] Univ Essen Gesamthsch, Clin Psychiat & Psychotherapy, D-45147 Essen, Germany
关键词
D O I
10.1001/archpsyc.55.11.1048
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:1048 / 1050
页数:3
相关论文
共 9 条
[1]   CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST [J].
BERTILSSON, L ;
CARRILLO, JA ;
DAHL, ML ;
LLERENA, A ;
ALM, C ;
BONDESSON, U ;
LINDSTROM, L ;
DELARUBIA, IR ;
RAMOS, S ;
BENITEZ, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (05) :471-473
[2]  
CARILLO JA, 1996, CLIN PHARMACOL THER, V60, P183
[3]   Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity [J].
Casley, WL ;
Menzies, JA ;
Mousseau, N ;
Girard, M ;
Moon, TW ;
Whitehouse, LW .
PHARMACOGENETICS, 1997, 7 (04) :283-293
[4]   SIMPLE AND RELIABLE CYP1A2 PHENOTYPING BY THE PARAXANTHINE/CAFFEINE RATIO IN PLASMA AND IN SALIVA [J].
FUHR, U ;
ROST, KL .
PHARMACOGENETICS, 1994, 4 (03) :109-116
[5]  
HIEMKE C, 1994, J CLIN PSYCHOPHARM, V14, P279
[6]   EXPRESSION OF CYP1A1 AND CYP1A2 GENES IN HUMAN LIVER [J].
SCHWEIKL, H ;
TAYLOR, JA ;
KITAREEWAN, S ;
LINKO, P ;
NAGORNEY, D ;
GOLDSTEIN, JA .
PHARMACOGENETICS, 1993, 3 (05) :239-249
[7]   Fluvoxamine augmentation in clozapine-resistant schizophrenia: An open pilot study [J].
Silver, H ;
Kushnir, M ;
Kaplan, A .
BIOLOGICAL PSYCHIATRY, 1996, 40 (07) :671-674
[8]   IMPROVED EFFICACY AND FEWER SIDE-EFFECTS UNDER CLOZAPINE TREATMENT AFTER ADDITION OF FLUVOXAMINE [J].
SZEGEDI, A ;
WIESNER, J ;
HIEMKE, C .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (02) :141-143
[9]   CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH SCHIZOPHRENIA WHO ARE UNRESPONSIVE TO OR INTOLERANT OF CLASSICAL ANTIPSYCHOTIC AGENTS [J].
WAGSTAFF, AJ ;
BRYSON, HM .
CNS DRUGS, 1995, 4 (05) :370-400